Gonadoblastoma medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m (Bot: Removing from Primary care) |
||
| Line 12: | Line 12: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Medicine]] | [[Category:Medicine]] | ||
[[Category:Oncology]] | [[Category:Oncology]] | ||
[[Category:Gynecology]] | [[Category:Gynecology]] | ||
[[Category:Up-To-Date]] | [[Category:Up-To-Date]] | ||
Revision as of 21:54, 29 July 2020
|
Gonadoblastoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Gonadoblastoma medical therapy On the Web |
|
American Roentgen Ray Society Images of Gonadoblastoma medical therapy |
|
Risk calculators and risk factors for Gonadoblastoma medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]
Overview
The mainstay of treatment for gonadoblastoma is surgery. Hormonal replacement therapy may be considered depending on the underlying condition.
Medical Therapy
- Hormonal replacement therapy may be done depending on the patient and presence or absence of vaginal bleeding and/or virilization.[1]
References
- ↑ Sperling, M (2014). Pediatric endocrinology. Philadelphia, PA: Elsevier/Saunders. ISBN 978-1-4557-4858-7.